Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

MRI is a diagnostic test that doctors use to diagnose and track the progress of amyotrophic lateral sclerosis (ALS). ALS is a progressive disease that damages nerve cells in the brain and spinal ...

Visualising multiple sclerosis with a new MRI procedure. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 02 / 240208122039.htm ...

A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data suggested.

More information: Jing-Ping Lin et al, 4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis–like lesions, Science (2025). DOI: 10.1126/science.adp6325 ...

MRI indicators included in the analysis were brain parenchymal fraction, gray matter fraction, and T2 lesion volume, quantified using standard MRI techniques. 16 Fatigue was measured using the ...